Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension

Figure 8

Comparison of % drug release of Nateglinide sustained release tablets (N1–N13).